Murdoch Childrens Research Institute Mar 10 2026 A new biotech company forged through an Australian and Danish partnership will accelerate treatments for children and adults with heart disease. Harnessing cellular therapies, the company aims to conduct human clinical trials within three to five years. Ibnova Therapeutics, launched today, has emerged from world-first, collaborative research by Murdoch Children's Research Institute (MCRI) in Melbourne and QIMR Berghofer in Brisbane. Within MCRI,